Literature DB >> 13346383

Two cases of myopathy limited to the quadriceps.

J N WALTON.   

Abstract

Entities:  

Keywords:  MUSCLES/diseases

Mesh:

Year:  1956        PMID: 13346383      PMCID: PMC497192          DOI: 10.1136/jnnp.19.2.106

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  On the classification, natural history and treatment of the myopathies.

Authors:  J N WALTON; F J NATTRASS
Journal:  Brain       Date:  1954       Impact factor: 13.501

2.  The clinical features and response to cortisone of menopausal muscular dystrophy.

Authors:  G M SHY; D McEACHERN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1951-05       Impact factor: 10.154

3.  Myopathic Weakness of Quadriceps.

Authors:  D Denny-Brown
Journal:  Proc R Soc Med       Date:  1939-06
  3 in total
  6 in total

1.  "Quadriceps myopathy": a clinical variant form of Becker muscular dystrophy.

Authors:  Y Wada; Y Itoh; T Furukawa; H Tsukagoshi; K Arahata
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

2.  [A rarely observed familial form of progressive muscular dystrophy in adulthood].

Authors:  F FUNK
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1962

3.  Quadriceps myopathy occurring in middle age.

Authors:  J W TURNER; K W HEATHFIELD
Journal:  J Neurol Neurosurg Psychiatry       Date:  1961-02       Impact factor: 10.154

4.  Chronic neurogenic quadriceps amyotrophies.

Authors:  G Serratrice; A Pou-Serradel; J F Pellissier; H Roux; J Lamarco-Civro; J Pouget
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

5.  Familial muscular dystrophy of late onset.

Authors:  P A Bacon; B Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

6.  Quadriceps myopathy: a variant of the limb-girdle dystrophy syndrome.

Authors:  M Swash; K W Heathfield
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-04       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.